Atrys Health (Spain) Price Prediction
ATRY Stock | EUR 3.07 0.02 0.65% |
Oversold Vs Overbought
54
Oversold | Overbought |
Using Atrys Health hype-based prediction, you can estimate the value of Atrys Health SL from the perspective of Atrys Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Atrys Health to buy its stock at a price that has no basis in reality. In that case, they are not buying Atrys because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Atrys Health after-hype prediction price | EUR 3.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Atrys |
Atrys Health After-Hype Price Prediction Density Analysis
As far as predicting the price of Atrys Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Atrys Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Atrys Health, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Atrys Health Estimiated After-Hype Price Volatility
In the context of predicting Atrys Health's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Atrys Health's historical news coverage. Atrys Health's after-hype downside and upside margins for the prediction period are 1.40 and 4.78, respectively. We have considered Atrys Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Atrys Health is slightly risky at this time. Analysis and calculation of next after-hype price of Atrys Health SL is based on 3 months time horizon.
Atrys Health Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Atrys Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atrys Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Atrys Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 1.70 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.07 | 3.09 | 0.00 |
|
Atrys Health Hype Timeline
Atrys Health SL is presently traded for 3.07on Madrid Exchange of Spain. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Atrys is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.07%. %. The volatility of related hype on Atrys Health is about 0.0%, with the expected price after the next announcement by competition of 3.07. About 78.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atrys Health SL recorded a loss per share of 0.46. The entity had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Atrys Health Basic Forecasting Models to cross-verify your projections.Atrys Health Related Hype Analysis
Having access to credible news sources related to Atrys Health's direct competition is more important than ever and may enhance your ability to predict Atrys Health's future price movements. Getting to know how Atrys Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Atrys Health may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
PHM | Pharma Mar SA | 0.00 | 0 per month | 1.24 | 0.23 | 4.75 | (1.95) | 38.62 | |
ATRY | Atrys Health SL | 0.00 | 0 per month | 0.00 | (0.13) | 3.74 | (2.54) | 8.76 | |
MVC | Metrovacesa SA | 0.00 | 0 per month | 0.68 | (0.01) | 1.76 | (1.39) | 3.85 | |
ENO | Elecnor SA | 0.00 | 0 per month | 0.78 | 0.08 | 1.72 | (1.37) | 7.16 | |
MAP | Mapfre | 0.00 | 0 per month | 0.81 | 0.05 | 2.07 | (1.61) | 7.45 | |
ALC | Altia Consultores SA | 0.00 | 0 per month | 2.17 | (0.04) | 2.53 | (4.20) | 14.26 | |
CCEP | Coca Cola European Partners | 0.00 | 0 per month | 0.89 | (0.05) | 2.52 | (2.19) | 6.94 | |
CLNX | Cellnex Telecom SA | 0.00 | 0 per month | 0.00 | (0.11) | 2.27 | (2.44) | 6.49 |
Atrys Health Additional Predictive Modules
Most predictive techniques to examine Atrys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Atrys using various technical indicators. When you analyze Atrys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Atrys Health Predictive Indicators
The successful prediction of Atrys Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Atrys Health SL, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Atrys Health based on analysis of Atrys Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Atrys Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Atrys Health's related companies.
Story Coverage note for Atrys Health
The number of cover stories for Atrys Health depends on current market conditions and Atrys Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Atrys Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Atrys Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Atrys Health Short Properties
Atrys Health's future price predictability will typically decrease when Atrys Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Atrys Health SL often depends not only on the future outlook of the potential Atrys Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atrys Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 53.5 M | |
Cash And Short Term Investments | 40.6 M |
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |